US Personalised Medicine Market On the Up: PwC

9 December 2009 (Last Updated December 9th, 2009 18:30)

The US market for personalised medicine is worth $232bn and is expected to grow by 11% annually, according to a report. The PricewaterhouseCoopers (PwC) report said that the market will grow to $452bn by 2015. Personalised medicine targets individualised treatment and care ba

The US market for personalised medicine is worth $232bn and is expected to grow by 11% annually, according to a report.

The PricewaterhouseCoopers (PwC) report said that the market will grow to $452bn by 2015.

Personalised medicine targets individualised treatment and care based on personal and genetic variation and is creating a booming market.

The core diagnostic and therapeutic segment of the market is comprised primarily of pharmaceutical, medical device and diagnostics companies and is estimated at $24bn.

This sector is expected to grow by 10% annually, reaching $42bn by 2015.